Neural intersection of chronic alcohol exposure and pain
Project Number1F31AA031431-01A1
Former Number1F31AA031431-01
Contact PI/Project LeaderBRANDNER, ADAM JOSEPH
Awardee OrganizationUNIVERSITY OF PITTSBURGH AT PITTSBURGH
Description
Abstract Text
Project Summary
Alcohol use disorder (AUD) is characterized as an impaired ability to stop or control alcohol use, leading to
compulsive intake, trouble limiting intake, and the occurrence of a negative affective state during alcohol
withdrawal. Many negative symptoms arise during alcohol withdrawal, including heightened sensitivity to
painful stimuli. Nearly 75% of individuals with AUD report experiencing pain as a result of their alcohol use, and
many of those individuals will use alcohol to try to cope with their pain. In addition, chronic alcohol exposure
contributes to the development of hyperalgesia and chronic pain in mice and rats during withdrawal. A better
understanding of the mechanisms that lead to the development and maintenance of pain in AUD patients is
needed. The parabrachial nucleus (PBN) projects to multiple brain areas involved in physiological processing,
including the central amygdala, and this pathway is considered to be a hub for pain and aversion.
Glutamatergic PBN neurons express neuropeptide Y (NPY) receptor 1 (Y1), and chronic alcohol exposure can
reduce CNS Y1 expression. Additionally, our preliminary work illustrates PBN Y1 neurons project to the CeA.
Y1s work to inhibit neuronal functioning and our laboratory has found that activation of Y1 receptors on PBN
neurons reduces neuropathic pain-like behavior in mice.
My central hypothesis is that chronic alcohol exposure increases the activity of PBN Y1 neurons, leading to
sensory and affective components of chronic alcohol withdrawal induced pain (CAWIP). I predict PBN Y1
neuron activity is increased during alcohol withdrawal, and that inhibiting PBN Y1 neurons will attenuate pain
associated with alcohol withdrawal. Specific Aim 1 will determine activity of PBN Y1 neurons in alcohol
withdrawn mice during nociception. Specific Aim 2 will inhibit PBN Y1 neurons and pharmacologically activate
PBN Y1 receptors to attenuate hypersensitivity associated with alcohol withdrawal. Conducting these
experiments will elucidate the PBN Y1 circuitry that underlies CAWIP.
Public Health Relevance Statement
Project Narrative
Pain is a hallmark symptom in nearly 75% of individuals with AUD, however, the underlying mechanisms of
chronic alcohol withdrawal induced pain (CAWIP) are not known. The parabrachial nucleus of the brainstem
controls both behavioral reflexive and affective components of pain. This proposal will investigate changes in
Y1 neuron activity and function in the parabrachial nucleus as a result of chronic alcohol exposure.
National Institute on Alcohol Abuse and Alcoholism
CFDA Code
273
DUNS Number
004514360
UEI
MKAGLD59JRL1
Project Start Date
01-July-2024
Project End Date
30-June-2027
Budget Start Date
01-July-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$48,974
Direct Costs
$48,974
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2024
National Institute on Alcohol Abuse and Alcoholism
$48,974
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1F31AA031431-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1F31AA031431-01A1
Patents
No Patents information available for 1F31AA031431-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1F31AA031431-01A1
Clinical Studies
No Clinical Studies information available for 1F31AA031431-01A1
News and More
Related News Releases
No news release information available for 1F31AA031431-01A1
History
No Historical information available for 1F31AA031431-01A1
Similar Projects
No Similar Projects information available for 1F31AA031431-01A1